자료문의: 02 703 5000        
all of these words any of these words

전세계 전자 약물전달 시스템 시장 2024
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
◇발행처: MNM    ◇발행일: 2019년 10월   ◇가격: $5,650[PDF]    ◇페이지수: 125쪽   
-> 전체보기
경박단소화에의 신기술 :신제...

50% 할인문의
info@oic.co.kr

목차
요약
목록으로 돌아가기      
 
    
 Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
    2.3 Data Triangulation Approach
    2.4 Market Share Analysis
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 28)
    4.1 Electronic Drug Delivery Systems: Market Overview
    4.2 North America: Market, By Type, 2018
    4.3 Geographical Snapshot of the Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Prevalence of Target Diseases
                    5.2.1.2 Favorable Reimbursement Scenario in Major Markets
                    5.2.1.3 Advancements in Technologies and Designs
           5.2.2 Restraints
                    5.2.2.1 Preference for Alternative Drug Delivery Modes and the Possibility of Errors
           5.2.3 Opportunities
                    5.2.3.1 Increasing Demand for Biologics and Mabs
                    5.2.3.2 Growth Opportunities in Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 Unfavorable Reimbursement Structure in Developing Countries

6 Market, By Type (Page No. - 36)
    6.1 Introduction
           6.1.1 Electronic Wearable Infusion Pumps
                    6.1.1.1 Electronic Wearable Infusion Pumps Dominate the Market
           6.1.2 Electronic Autoinjectors
                    6.1.2.1 Electronic Autoinjectors are Likely to Register Negative Growth During the Forecast Period Due to the Continuous Influx of Generic Versions of Conventional Autoinjectors in the Market
           6.1.3 Electronic Injection Pens
                    6.1.3.1 Growing Focus of Pharmaceutical Companies on Developing Electronic/Connected Injection Pens Will Drive Market Growth
           6.1.4 Electronic Inhalers
                    6.1.4.1 Electronic Inhalers are Developed to Improve Medication Adherence in Asthma & COPD Management

7 Market, By Indication (Page No. - 48)
    7.1 Introduction
    7.2 Diabetes
           7.2.1 Diabetes Accounted for the Largest Segment of the Market
    7.3 Multiple Sclerosis
           7.3.1 Launch of Generic Versions of Conventional Injectables Will Stifle Market Growth
    7.4 Cardiovascular Disease
           7.4.1 Development of Innovative Electronic Drug Delivery Systems for Cvd Treatment Will Drive Market Growth
    7.5 Asthma & COPD
           7.5.1 Development of Smart Inhalers and Digital Sensors is Likely to Improve Medication Adherence in Asthma & COPD Patients
    7.6 Other Indications

8 Market, By Region (Page No. - 61)
    8.1 Introduction
    8.2 North America
           8.2.1 US
                    8.2.1.1 The US has A Favorable Reimbursement Scenario for Electronic Drug Delivery Devices, Which is A Key Factor Driving the Market for Electronic Drug Delivery Systems
           8.2.2 Canada
                    8.2.2.1 Growing Presence of Device Manufacturers in the Country is Expected to Propel Market Growth
    8.3 Europe
           8.3.1 Germany
                    8.3.1.1 Germany is the Largest Market for Electronic Drug Delivery Systems in Europe
           8.3.2 UK
                    8.3.2.1 High Burden of Target Diseases to Support Market Growth
           8.3.3 France
                    8.3.3.1 High Prevalence of Diabetes in the Country to Propel Market Growth
           8.3.4 Rest of Europe
    8.4 Asia Pacific
           8.4.1 Japan
                    8.4.1.1 Large Geriatric Population and the High Prevalence of Cvd to Support Market Growth
           8.4.2 China
                    8.4.2.1 Growing Focus of Major Players on Biologics Development to Drive Market Growth
           8.4.3 India
                    8.4.3.1 Lack of Reimbursement and Guidelines on Electronic Drug Delivery Systems Could Limit Market Growth
           8.4.4 RoAPAC
    8.5 Rest of the World
           8.5.1 Latin America
                    8.5.1.1 High Incidence of Chronic Diseases to Drive the Demand for Electronic Drug Delivery Systems
           8.5.2 Middle East & Africa
                    8.5.2.1 Favorable Reforms in South Africa to Support Market Growth

9 Competitive Landscape (Page No. - 88)
    9.1 Overview
    9.2 Market Share Analysis
    9.3 Key Player Analysis
           9.3.1 Merck Group
           9.3.2 Medtronic PLC
    9.4 Competitive Scenario
           9.4.1 Product Launches
           9.4.2 Expansions
           9.4.3 Agreements & Collaborations
    9.5 Competitive Leadership Mapping (2018)
           9.5.1 Visionary Leaders
           9.5.2 Innovators
           9.5.3 Dynamic Differentiators
           9.5.4 Emerging Companies

10 Company Profiles (Page No. - 94)
     10.1 Merck Group
             10.1.1 Business Overview
             10.1.2 Products Offered
             10.1.3 Recent Developments
     10.2 Medtronic PLC
             10.2.1 Business Overview
             10.2.2 Products Offered
             10.2.3 Recent Developments
     10.3 United Therapeutics Corporation
             10.3.1 Business Overview
             10.3.2 Products Offered
             10.3.3 Recent Developments
     10.4 Insulet Corporation
             10.4.1 Business Overview
             10.4.2 Products Offered
             10.4.3 Recent Developments
     10.5 Bayer AG
             10.5.1 Business Overview
             10.5.2 Products Offered
             10.5.3 Recent Developments
     10.6 Novo Nordisk
             10.6.1 Business Overview
             10.6.2 Products Offered
             10.6.3 Recent Developments
     10.7 Companion Medical
             10.7.1 Business Overview
             10.7.2 Products Offered
             10.7.3 Recent Developments
     10.8 Tandem Diabetes Care, Inc.
             10.8.1 Business Overview
             10.8.2 Products Offered
             10.8.3 Recent Developments
     10.9 F.Hoffmann-La Roche, Ltd.
             10.9.1 Business Overview
             10.9.2 Products Offered
             10.9.3 Recent Developments
     10.10 Amgen, Inc.
             10.10.1 Business Overview
             10.10.2 Products Offered
             10.10.3 Recent Developments
     10.11 Astrazeneca PLC
             10.11.1 Business Overview
             10.11.2 Products Offered
             10.11.3 Recent Developments
     10.12 Findair SP. Z O. O.
             10.12.1 Business Overview
             10.12.2 Products Offered
             10.12.3 Recent Developments
     10.13 Vicentra B.V.
             10.13.1 Business Overview
             10.13.2 Products Offered
             10.13.3 Recent Developments
     10.14 Canè SPA
             10.14.1 Business Overview
             10.14.2 Products Offered
     10.15 Debiotech S.A.
             10.15.1 Business Overview
             10.15.2 Products Offered

11 Appendix (Page No. - 119)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets’  Subscription Portal
     11.3 Related Reports
     11.4 Author Details


List of Tables (86 Tables)

Table 1 Commercially Available Biologics as Potential Applications for Electronic Drug Delivery Systems in the Coming Years
Table 2 Market, By Type, 2017–2024 (usD Million)
Table 3 Electronic Drug Delivery Systems Market, By Product, 2017–2024 (usD Million)
Table 4 Comparative Table of Commercially Available Insulin Pumps
Table 5 Electronic Wearable Infusion Pumps Market, By Region, 2017–2024 (USD Million)
Table 6 North America: Electronic Wearable Infusion Pumps Market, By Country, 2017–2024 (USD Million)
Table 7 Europe: Electronic Wearable Infusion Pumps Market, By Country, 2017–2024 (USD Million)
Table 8 Asia Pacific: Electronic Wearable Infusion Pumps Market, By Country, 2017–2024 (USD Million)
Table 9 RoW: Electronic Wearable Infusion Pumps Market, By Region, 2017–2024 (USD Million)
Table 10 Electronic Autoinjectors Market, By Region, 2017–2024 (USD Million)
Table 11 North America: Electronic Autoinjectors Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: Electronic Autoinjectors Market, By Country, 2017–2024 (USD Million)
Table 13 Asia Pacific: Electronic Autoinjectors Market, By Country, 2017–2024 (USD Million)
Table 14 RoW: Electronic Autoinjectors Market, By Region, 2017–2024 (USD Million)
Table 15 Electronic Injection Pens Market, By Region, 2017–2024 (USD Million)
Table 16 North America: Electronic Injection Pens Market, By Country, 2017–2024 (USD Million)
Table 17 Europe: Electronic Injection Pens Market, By Country, 2017–2024 (USD Million)
Table 18 Asia Pacific: Electronic Injection Pens Market, By Country, 2017–2024 (USD Million)
Table 19 RoW: Electronic Injection Pens Market, By Region, 2017–2024 (USD Million)
Table 20 Electronic Inhalers Market, By Country, 2017–2024 (USD Million)
Table 21 Market, By Indication, 2017–2024 (USD Million)
Table 22 Top Five Countries With the Highest Number of Diabetics (20–79 Years), 2017 vs. 2045
Table 23 Electronic Drug Delivery Systems Market for Diabetes, By Region, 2017–2024 (USD Million)
Table 24 North America: Market for Diabetes, By Country, 2017–2024 (USD Million)
Table 25 Europe: Market for Diabetes, By Country, 2017–2024 (USD Million)
Table 26 Asia Pacific: Market for Diabetes, By Country, 2017–2024 (USD Million)
Table 27 RoW: Market for Diabetes, By Region, 2017–2024 (USD Million)
Table 28 Market for Multiple Sclerosis, By Region, 2017–2024 (USD Million)
Table 29 North America: Market for Multiple Sclerosis, By Country, 2017–2024 (USD Million)
Table 30 Europe: Market for Multiple Sclerosis, By Country, 2017–2024 (USD Million)
Table 31 Asia Pacific: Market for Multiple Sclerosis, By Country, 2017–2024 (USD Million)
Table 32 RoW: Market for Multiple Sclerosis, By Region, 2017–2024 (USD Million)
Table 33 Market for Cardiovascular Disease, By Region, 2017–2024 (USD Million)
Table 34 North America: Market for Cardiovascular Disease, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Cardiovascular Disease, By Country, 2017–2024 (USD Million)
Table 36 Asia Pacific: Market for Cardiovascular Disease, By Country, 2017–2024 (USD Million)
Table 37 RoW: Market for Cardiovascular Disease, By Region, 2017–2024 (USD Million)
Table 38 Prevalence of COPD & Asthma in 2010 and 2016 (Million)
Table 39 Market for Asthma & COPD, By Country, 2017–2024 (USD Million)
Table 40 Market for Other Indications, By Region, 2017–2024 (USD Million)
Table 41 North America: Market for Other Indications, By Country, 2017–2024 (USD Million)
Table 42 Europe: Market for Other Indications, By Country, 2017–2024 (USD Million)
Table 43 Asia Pacific: Market for Other Indications, By Country, 2017–2024 (USD Million)
Table 44 RoW: Market for Other Indications, By Region, 2017–2024 (USD Million)
Table 45 Market, By Region, 2017–2024 (USD Million)
Table 46 Market, By Country, 2017–2024 (USD Million)
Table 47 North America: Market, By Country, 2017–2024 (USD Million)
Table 48 North America: Market, By Type, 2017–2024 (USD Million)
Table 49 North America: Market, By Indication, 2017–2024 (USD Million)
Table 50 US: Market, By Type, 2017–2024 (USD Million)
Table 51 US: Market, By Indication, 2017–2024 (USD Million)
Table 52 Canada: Market, By Type, 2017–2024 (USD Million)
Table 53 Canada: Market, By Indication, 2017–2024 (USD Million)
Table 54 Europe: Recent Developments in the Market, 2017–2018
Table 55 Europe: Market, By Country, 2017–2024 (USD Million)
Table 56 Europe: Market, By Type, 2017–2024 (USD Million)
Table 57 Europe: Market, By Indication, 2017–2024 (USD Million)
Table 58 Germany: Market, By Type, 2017–2024 (USD Million)
Table 59 Germany: Market, By Indication, 2017–2024 (USD Million)
Table 60 UK: Market, By Type, 2017–2024 (USD Million)
Table 61 UK: Market, By Indication, 2017–2024 (USD Million)
Table 62 France: Electronic Drug Delivery Systems Market, By Type, 2017–2024 (USD Million)
Table 63 France: Market, By Indication, 2017–2024 (USD Million)
Table 64 RoE: Market, By Type, 2017–2024 (USD Million)
Table 65 RoE: Market, By Indication, 2017–2024 (USD Million)
Table 66 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 67 Asia Pacific: Market, By Type, 2017–2024 (USD Million)
Table 68 Asia Pacific: Market, By Indication, 2017–2024 (USD Million)
Table 69 Japan: Market, By Type, 2017–2024 (USD Million)
Table 70 Japan: Market, By Indication, 2017–2024 (USD Million)
Table 71 China: Market, By Type, 2017–2024 (USD Million)
Table 72 China: Market, By Indication, 2017–2024 (USD Million)
Table 73 India: Market, By Type, 2017–2024 (USD Million)
Table 74 India: Market, By Indication, 2017–2024 (USD Million)
Table 75 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 76 RoAPAC: Market, By Indication, 2017–2024 (USD Million)
Table 77 RoW: Market, By Region, 2017–2024 (USD Million)
Table 78 RoW: Market, By Type, 2017–2024 (USD Million)
Table 79 RoW: Market, By Indication, 2017–2024 (USD Million)
Table 80 Latin America: Market, By Type, 2017–2024 (USD Million)
Table 81 Latin America: Market, By Indication, 2017–2024 (USD Million)
Table 82 Middle East & Africa: Market, By Type, 2017–2024 (USD Million)
Table 83 Middle East & Africa: Market, By Indication, 2017–2024 (USD Million)
Table 84 Product Launches
Table 85 Expansions
Table 86 Agreements & Collaborations


List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Electronic Drug Delivery Systems Market Share, By Type, 2018
Figure 7 Market Share, By Indication, 2018
Figure 8 Geographic Snapshot: stems Market, 2018
Figure 9 Growing Prevalence of Chronic Diseases is Likely to Drive the Market for Electronic Drug Delivery Systems
Figure 10 Electronic Wearable Infusion Pumps Accounted for the Largest Share of the North American Market in 2018
Figure 11 North America to Witness the Highest Growth During the Forecast Period
Figure 12 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 13 Market, By Type, 2019 vs. 2024 (USD Million)
Figure 14 Market, By Indication, 2019 vs. 2024 (USD Million)
Figure 15 Market, By Region, 2019 vs. 2024
Figure 16 North America: Market Snapshot 65
Figure 17 Europe: Market Snapshot
Figure 18 Asia Pacific: Market Snapshot
Figure 19 RoW: Market Snapshot
Figure 20 Market Share Analysis By Key Players (2018)
Figure 21 Competitive Leadership Mapping: Market
Figure 22 Merck Group: Company Snapshot
Figure 23 Medtronic PLC: Company Snapshot
Figure 24 United Therapeutics Corporation: Company Snapshot
Figure 25 Insulet Corporation: Company Snapshot
Figure 26 Bayer AG: Company Snapshot
Figure 27 Exchange Rate (Utilized for the Conversion of Eur to USD)
Figure 28 Novo Nordisk: Company Snapshot
Figure 29 Tandem Diabetes Care, Inc.: Company Snapshot
Figure 30 F.Hoffmann-La Roche Ltd.: Company Snapshot
Figure 31 Amgen: Company Snapshot
Figure 32 Astrazeneca PLC: Company Snapshot

Title: Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
 
주의: 로그인 후 바구니에 담거나 구매해 주세요.      
 

 

의료용 주입펌프
Drug Delivery
통신
전자
중공업
제약
화학
의학
환경
식품
방위산업
기타
   .
   .
   .
   .
   .
   .
   .
ID(email)
Password
비밀번호 분실 회원가입

Copyrightⓒ2019 OIC(Overseas Information Center) All Rights Reserved.
04373 서울시 용산구 이촌로 1(GS한강에클라트) 1121호
E_mail : info@oic.co.kr Tel: 02-703-5000 Fax: 02-714-1109 /개인정보 취급방침